Venture Life Group (VLG.L) Osake Kurssi
Venture Life Group Kurssi
Viimeisten 15 vuoden aikana Venture Life Groupn liikevaihto kasvoi 47,7 % vuodessa ja ylsi 35,17 M GBP:een. Osakekohtainen tulos on kasvanut 49,4 % vuodessa viimeisten 7 vuoden aikana. Venture Life Groupn nettomarginaali 17,4 % on noussut verrattuna 7,3 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 0,06 %. Jakosuhde on noin 15 % tuloksesta. Venture Life Groupn 12 kuukauden konsensustavoitehinta on 102,00 GBP, noin yli kurssia 15 123,9 %. 9 analyytikosta 8 suosittaa ostoa — kokonaiskonsensus on Osta.
Venture Life Group osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Venture Life Group liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Venture Life Group -osakkeesta
The business model of Venture Life Group PLC focuses on the development, manufacturing, and commercialization of innovative products in the healthcare sector. By leveraging their expertise and strategic partnerships, Venture Life Group PLC creates and sells a range of medical devices, cosmetics, and nutritional products. They aim to improve the quality of life for their customers by providing high-quality, scientifically validated solutions. Through continuous research and development, Venture Life Group PLC stays at the forefront of the industry, ensuring their products meet the evolving needs of healthcare professionals and end-users.
Venture Life Group PLC is primarily active in the healthcare and consumer wellness industries. The company focuses on developing, manufacturing, and marketing a wide range of innovative products in these sectors. With a strong emphasis on quality and customer satisfaction, Venture Life Group PLC aims to meet the diverse needs of individuals across various healthcare segments. This dedication has positioned the company as a leading player in the healthcare industry, providing effective solutions and improving the well-being of consumers worldwide.
The main competitors of Venture Life Group PLC in the market are companies like Johnson & Johnson, Procter & Gamble, and Unilever.
Venture Life Group PLC is a UK-based international consumer healthcare company. Founded in 2010, the company focuses on the development, manufacturing, and commercialization of innovative products for the self-care market. Venture Life Group PLC offers a wide range of products, including medical devices, oral care products, and dermatological solutions. With a strong track record of delivering high-quality products, the company has expanded its presence across Europe and other international markets. Venture Life Group PLC's commitment to innovation and its strategic partnerships with leading healthcare companies have contributed to its success in providing effective and accessible healthcare solutions globally.
Venture Life Group PLC has achieved several significant milestones throughout its journey. The company successfully expanded its product portfolio by launching innovative brands and entering into strategic partnerships. They have also demonstrated impressive market growth and secured distribution agreements in multiple regions. Moreover, Venture Life Group PLC has consistently maintained a strong financial position, generating substantial revenue and delivering impressive shareholder returns. These achievements highlight the company's successful track record and commitment to driving growth and excellence in the healthcare industry.
Venture Life Group PLC is primarily present in multiple countries and regions. The company has an extensive international presence with its operations spanning across Europe, Asia, and the Middle East. Some key countries where Venture Life Group PLC operates include the United Kingdom, Italy, Spain, Portugal, France, Germany, the Netherlands, China, and the United Arab Emirates. With its focus on global expansion, Venture Life Group PLC continues to establish a strong presence in these regions, combining its expertise in the healthcare and consumer wellness sectors to provide innovative solutions to customers worldwide.
Venture Life Group PLC is a company that values innovation, excellence, and integrity in all aspects of its operations. Their corporate philosophy is centered around delivering high-quality healthcare and personal care products to customers worldwide. With a focus on research and development, Venture Life Group PLC aims to enhance people's lives through their innovative product offerings. Their commitment to ethical practices and sustainable growth makes them a trusted choice for customers seeking reliable healthcare solutions. Venture Life Group PLC's dedication to customer satisfaction and continuous improvement sets them apart in the industry, making them a leading player in the global healthcare market.
Analyytikot asettavat tällä hetkellä Venture Life Group-osakkeelle keskimääräisen tavoitehinnan 102,00 GBP (mediaani: 102,00 GBP), mikä merkitsee +52,2 % viimeisimpään hintaan verrattuna. Konsensus perustuu 9 analyytikkoarvioon.
9 analyytikkoa arvioi tällä hetkellä Venture Life Group-osaketta: 8 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Venture Life Group-yhtiöltä 42,40 M GBP liikevaihtoa ja 0,00 GBP osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Venture Life Group-osake noteerataan hintaan 0,80 EUR (0,67 GBP).
Venture Life Group-osake (VLG.L) on listattuna 3 pörssissä, muun muassa: London (VLG.L), Frankfurt (17V.F).
The Venture Life Group PLC is a global consumer goods company in the health and wellness sector, focusing on the development and marketing of products for the over-the-counter (OTC) and professional markets. The company operates in four business segments: the dermatology category, the oral health category, the animal health category, and the lifestyle products category. The dermatology category develops and distributes products for the treatment of skin problems such as acne, eczema, psoriasis, and skin infections. Some of the brand-name products include DermaSilk, UltraDEX, and New Skin. In the oral health category, Venture Life produces mouthwashes and toothpastes tailored to specific needs. They have several brands in their portfolio, including UltraDEX, NeuBrite, and Dentyl. The animal health category includes a wide range of health and wellness products for pets. The product range includes shampoos, lotions, wound creams, vitamin supplements, and flea and tick treatments. The products are available under the brand names Proderm, Vetruus, and UltraBeau. Lifestyle products are also offered, including Venetiaurum, a dietary supplement for skin, hair, and nails; Kultura, a probiotic for the gut; and Lubatti, a luxurious beauty salon. Venture Life Group's business model is based on product development and distribution, with a focus on innovation and quality. The company utilizes an efficient and agile business model that accelerates the development process from idea to market launch and reduces administrative costs. Venture Life works closely with research and development departments as well as external partner companies to leverage innovative technologies, active ingredients, and platforms for the development of new products. The company also places great importance on its international distribution channels and works with leading retailers worldwide to promote the distribution of its products. Online sales platforms also play a major role in the business model, including the company's own website, which is available to customers in the EU, North America, and Asia. Venture Life Group PLC is a rapidly growing company with strong brands and a forward-thinking business model. It is a leading provider of health and wellness products for consumers and the professional market.
odotettu liikevaihto Venture Life Group on 42,40 M GBP. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Venture Life Group on 69 696,17 GBP. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Venture Life Group:n hinta-voitto-suhde (P/E) on tällä hetkellä 1 321,12. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Venture Life Group-osakkeen arvostusta.
Venture Life Group:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,17. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Venture Life Group-osakkeen arvostuskennuslukuna.
Venture Life Group:n Eulpool-laatuscore on 4/10.
Venture Life Group:n ISIN on GB00BFPM8908. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Venture Life Group:n WKN on A110ZQ. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Venture Life Group:n ticker on VLG.L. Tämä pörssinoteeraus käytetään Venture Life Group-osakkeiden kauppaan pörssissä.
Venture Life Group osake
Venture Life Group vertaisryhmä
Venture Life Group Ticker
Venture Life Group FIGI
Kaikki tunnusluvut ja syvällinen analyysi Venture Life Group:sta
Meidän osakeanalyysimme Venture Life Group-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Venture Life Group:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: